Form 4: Fortrea Holdings Director Edward Pesicka Awarded 38,817 Restricted Stock Units

Fortrea Holdings Inc. Director Edward A. Pesicka was granted 38,817 Restricted Stock Units (RSUs) on June 10, 2025, as part of a compensation award.

Summary

• Edward A. Pesicka, a Director of Fortrea Holdings Inc. (FTRE), was granted 38,817 Restricted Stock Units (RSUs).
• The transaction occurred on June 10, 2025, and was reported on a Form 4 filing dated June 12, 2025.
• Each RSU represents the right to receive one share of Fortrea Holdings Inc. Common Stock upon settlement.
• The RSU award vests in its entirety twelve months after June 10, 2025, contingent on Mr. Pesicka's continued service as a director.
• This grant was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged compensation award.

Sentiment

Score: 7

Explanation: The filing reports a standard equity compensation grant to a director, which is a positive for aligning management interests with shareholders, but it does not contain information that would significantly alter the company's financial outlook or operations.

Positives

• The grant of Restricted Stock Units to a director aligns the director's interests with long-term shareholder value, as the units vest over time and are subject to continued service.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged and compliant compensation award.

Risks

• The vesting of the Restricted Stock Units is subject to the reporting person's continued service as a director, meaning the award could be forfeited if service ceases before the vesting date.

Future Outlook

The vesting of the Restricted Stock Units in June 2026 indicates a future equity issuance to Director Edward A. Pesicka, contingent on his continued service, which will result in a minor dilution of existing shares upon conversion.

Industry Context

This Form 4 filing reports a routine equity compensation grant to a director, which is a common practice across industries to incentivize and retain key personnel by aligning their interests with long-term company performance. Such grants are standard components of executive and director compensation packages in the pharmaceutical services and contract research organization (CRO) sectors, where Fortrea Holdings Inc. operates.

Comparison to Industry Standards

• The grant of Restricted Stock Units (RSUs) as part of director compensation is a standard practice in the industry.
• Companies like IQVIA Holdings Inc. (IQV), Charles River Laboratories International, Inc. (CRL), and LabCorp (LH) also utilize equity awards, including RSUs, to compensate their directors and executives, aligning their interests with shareholder value.
• The specific number of units granted would typically be benchmarked against peer group compensation data, though this document does not provide such comparative details.

Stakeholder Impact

• Shareholders: The grant of RSUs to a director aligns the director's long-term interests with those of the shareholders, potentially encouraging decisions that enhance shareholder value.
• Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

• The 38,817 Restricted Stock Units are scheduled to vest in their entirety twelve months after June 10, 2025, subject to continued service, at which point they will convert into common stock.

Key Dates

Recommendation

Keywords

Fortrea Holdings Inc., FTRE, Restricted Stock Units, RSU, Director Compensation, SEC Form 4, Insider Transaction, Equity Award, Executive Compensation